Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CASC4 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA560201
Description
Immunogen sequence: NTYLVKRLEY ESFQCGQQMK ELRAQHEENI KKLADQFLEE QKQETQKIQS NDGKELDINN QVVPKNIPKV AENVADKNE Highest antigen sequence identity to the following orthologs: Mouse - 82%, Rat - 82%.
The increased expression level of this gene is associated with HER-2/neu proto-oncogene overexpression. Amplification and resulting overexpression of this proto-oncogene are found in approximately 30% of human breast and 20% of human ovarian cancers. Further characterization of the product of this gene may yield insight into the fundamental biology and pathogenetic effects of HER-2/neu overexpression in human breast and ovarian cancer cells. Alternatively spliced variants encoding different isoforms have been identified for this gene.
Specifications
CASC4 | |
Polyclonal | |
Unconjugated | |
CASC4 | |
cancer susceptibility candidate 4; cancer susceptibility candidate gene 4 protein; Cancer susceptibility candidate gene 4 protein homolog; Casc4; D130060C09Rik; gene associated with HER-2/neu overexpression; H63; Protein CASC4; UNQ2573/PRO6308; VGFG2573 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
113201 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q6P4E1 | |
CASC4 | |
Recombinant protein corresponding to Human CASC4. Recombinant protein control fragment (Product #RP-99877). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction